checkAd

    SULPHCO - Facts only - 500 Beiträge pro Seite

    eröffnet am 11.01.07 14:56:09 von
    neuester Beitrag 07.02.07 23:28:24 von
    Beiträge: 12
    ID: 1.104.601
    Aufrufe heute: 0
    Gesamt: 3.070
    Aktive User: 0

    Werte aus der Branche Sonstige Technologie

    WertpapierKursPerf. %
    7,7850+13,15
    29,52+13,10
    1,2500+10,62
    13,200+9,82
    18,855+9,11
    WertpapierKursPerf. %
    0,6746-6,28
    1,1000-7,56
    6,5600-9,52
    4,3800-12,40
    10,490-13,31

     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 11.01.07 14:56:09
      Beitrag Nr. 1 ()
      10.01.2007 17:19
      SulphCo(R) Inc. Announces Further Patent Update In Mexico

      SPARKS, Nev., Jan. 10 /PRNewswire-FirstCall/ -- SulphCo(R), Inc. today announced notice of its third patent now granted in Mexico.

      In a previous announcement the Company stated that it had been granted the Patent titled "Ultrasound-Assisted Desulfurization of Fossil Fuels in the Presence of Dialkyl Ethers" along with its first patent in Mexico titled, "Continuous Process for Oxidative Desulfurization of Fossil Fuels with Ultrasound and Products Thereof."

      The third patent granted is Patent Number 242552 "Corrosion resistant Ultrasonic Horn".

      Additionally, SulphCo (Nachrichten) has recently received notice of another application accepted but not yet granted titled "Oxidative Desulfurization of Fossil Fuels with Ultrasound".

      The company currently has three additional pending patents in Mexico.

      "Mexico, with its expanding daily heavy crude oil production, has become a strategic target for our technology and the granting of these patents for our Sonocracking(TM) Technology further establishes our progress in this market," said Dr. Rudolf W. Gunnerman, Chairman and CEO of SulphCo(R).

      SulphCo(R) currently has 5 issued patents on its proprietary Sonocracking(TM) Technology in the United States and a further six pending patents. The company also has numerous overseas patents and pending patents in major oil producing or consuming countries.

      SulphCo(R) Inc. works exclusively with its patent counsel Townsend and Townsend and Crew LLP on issues relating to the company's intellectual property.

      About SulphCo(R)

      SulphCo(R) has developed a patented safe and economic process employing ultrasound technology to desulfurize and hydrogenate crude oil and other oil related products. The company's technology upgrades sour heavy crude oils into sweeter, lighter crudes, producing more gallons of usable oil per barrel. From time to time, the company may issue forward-looking statements, which involve risks and uncertainties. This statement may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as actual results could differ and any forward-looking statements should be considered accordingly.

      ciao Dopi;)
      Avatar
      schrieb am 16.01.07 13:21:44
      Beitrag Nr. 2 ()
      ;)15.01.2007 21:10
      SulphCo Appoints New CEO and Chairman After Dispute

      SPARKS, Nev., Jan. 15 /PRNewswire-FirstCall/ -- SulphCo(R), Inc. announced today that the majority of the Board of Directors dismissed Dr. Rudolf W. Gunnerman as Chief Executive Officer and Chairman of the Company effective January 12, 2007. Dr. Gunnerman will continue to serve as a director of the Company. Larry Ryan, PhD, has been named the new Chief Executive Officer and Robert H. C. van Maasdijk has been appointed Chairman of the Board.

      Dr. Ryan comes to SulphCo (Nachrichten) from the General Electric Advanced Materials Division, where he led the Elastomers and RTV business. Dr. Ryan has a PhD from the University of Delaware, a Six-Sigma Blackbelt certification, and a long history of working with chemical process-dependent technologies. He is a graduate of the esteemed General Electric Edison Engineering Development Program, a technical leadership program focused on process engineering projects and product quality improvements. Dr. Ryan has a proven track record of delivering results in the area of new process-technology development.

      Robert H. C. van Maasdijk, a director of SulphCo since April 2005, is the former chairman and CEO of Attica Alternative Investment Fund, Ltd., a private investment fund which he headed since 1999. For the previous 16 years, he served as managing director and CEO of Lombard Odier Investment Portfolio Management Ltd., one of the oldest and largest private banks in Switzerland.

      Dr. Gunnerman had presented the Board with putative amended and restated By-laws which threatened the ability of the Board to function in the best interests of the shareholders. The Board rejected such changes as not being effective in accordance with applicable federal securities laws. The majority of the Board then proceeded with the dismissal of Dr. Gunnerman and will be asserting its control. The Board will also be seeking judicial relief in support of its actions.

      Mr. van Maasdijk said, "The manner in which the Board was forced to change management was unfortunate but it represents the next stage of development for the Company and the Board believes Dr. Ryan is well suited to drive the Company to future success." Mr. van Maasdijk stressed the importance of proving the validity of the mechanical and chemical aspects of the SonoCracking process, before launching a major marketing effort. Further, the majority of the Board believes Dr. Ryan is admirably well suited to this task. Dr. Ryan explained, "I am very excited to join the Company during this transition period and look forward to the challenges ahead." The new management team stated that SulphCo will immediately focus on commercial validation and enhancement of its SonoCracking technology.

      The SulphCo Board is committed to transparent communication internally and with the investor community. The Company will host an investor update, and question and answer session in the coming days introducing the new management team. A press release with exact date and time will be issued shortly.

      About SulphCo(R), Inc.

      SulphCo(R) has developed a patented safe and economic process employing ultrasound technology to desulfurize and hydrogenate crude oil and other oil related products. The company's technology upgrades sour heavy crude oils into sweeter, lighter crudes, producing more gallons of usable oil per barrel.

      From time to time, the company may issue forward-looking statements, which involve risks and uncertainties. This statement may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as actual results could differ and any forward-looking statements should be considered accordingly.
      Avatar
      schrieb am 18.01.07 17:34:35
      Beitrag Nr. 3 ()
      18.01.2007 17:22
      SulphCo's Largest Shareholder Files Suit Against Members of the Company's Board of Directors

      RENO, Nev., Jan. 18 /PRNewswire/ -- Dr. Rudolph W. Gunnerman, the former CEO and a director of SulphCo, (Nachrichten) Inc. ("SulphCo"), as well as the Company's largest shareholder, filed suit in the Second Judicial District Court of the State of Nevada against certain members of the Board of Directors of SulphCo. The actions which Dr. Gunnerman seeks to prevent are the directors' purported amendments of the Company's bylaws to increase the amount of shares of voting stock a shareholder must hold in order to call a Special Meeting of Shareholders to sixty-six and two-thirds percent (66 - 2/3%), as well as granting the authority to amend, alter, add, rescind or repeal the bylaws exclusively to the Board of Directors.

      "While I would have preferred not to have to go to court to enforce the rights of all shareholders, I strongly believe that the purported amendments unlawfully attempt to disenfranchise SulphCo's shareholders while entrenching the positions of the other directors," said Dr. Gunnerman. "The directors need to recognize that their duty is to the shareholders."

      A Notice of Special Telephonic Meeting of the Board of Directors of SulphCo was issued on January 16, 2007 for a meeting to commence at 11:30 a.m. on Wednesday, January 17, 2007. This Notice was issued mere hours after the filing of Dr. Gunnerman's Amended Schedule 13D, in which he describes his desire to force a shareholder meeting to allow shareholders to effect a change in the corporate leadership of SulphCo. The directors' purported amendments are designed and intended to prevent SulphCo's shareholders from calling a special shareholders' meeting and to make it impossible for those shareholders to amend or alter the corporate bylaws. Should these amendments become effective, the position of four individuals who hold an insignificant ownership position in SulphCo will be entrenched, while those who own a significant interest in the Company will be left without the ability to choose their representatives and without recourse.

      Contacts: Media: Investors and Analysts: Andrew Siegel / Michael Cuneo Charles Koons (212) 355-4449 (212) 929-5500 Joele Frank, Wilkinson Brimmer Katcher MacKenzie Partners, Inc.

      Dopi:cool:
      Avatar
      schrieb am 23.01.07 09:54:59
      Beitrag Nr. 4 ()
      SulphCo(R) Announces Investor Conference Call

      SPARKS, Nev., Jan. 22 /PRNewswire-FirstCall/ -- SulphCo(R), Inc. announced today that it will host a conference call on Monday, January 29th.

      Management has arranged this call as the first step to the Company's new transparency initiatives for investors and to introduce new CEO, Dr. Larry Ryan and Chairman of the Board, Robert van Massdijk. This call seeks to update investors on the status of various projects, the Sonocracking(R) process and other related technology.

      Dr. Larry Ryan, CEO of SulphCo (R) stated, "I look forward to alleviating any vagueness and restoring confidence for our loyal investors. We are establishing timelines, new investor communication procedures and fostering new relationships for the betterment of the Company."

      Dr. Ryan and Robert van Maasdijk, will be traveling to Fujairah this week for a facility tour and will have more details on Fujairah upon their return.

      Dr. Ryan and Robert van Massdijk, will host the conference call which will include an open forum for questions and answers at the end of their presentation. Details of the call will be provided in an upcoming press release.

      About SulphCo(R), Inc.

      SulphCo(R) has developed a patented safe and economic process employing ultrasound technology to desulfurize and hydrogenate crude oil and other oil related products. The company's technology upgrades sour heavy crude oils into sweeter, lighter crudes, producing more gallons of usable oil per barrel.

      From time to time, the company may issue forward-looking statements, which involve risks and uncertainties. This statement may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as actual results could differ and any forward-looking statements should be considered accordingly.


      Quelle: PR Newswire
      :cool:
      Avatar
      schrieb am 23.01.07 11:57:10
      Beitrag Nr. 5 ()
      Link zur SulphCo HP:http://www.sulphco.com/
      ;)

      Trading Spotlight

      Anzeige
      InnoCan Pharma
      0,1900EUR +2,98 %
      InnoCan Pharma: Ist das die nächste Milliarden-CBD-Übernahmestory? mehr zur Aktie »
      Avatar
      schrieb am 24.01.07 20:02:33
      Beitrag Nr. 6 ()
      24.01.2007 17:46
      Members of SulphCo's(R) Board of Directors Counterclaim Against Former Chairman and CEO R. W. Gunnerman

      SPARKS, Nev., Jan. 24 /PRNewswire-FirstCall/ -- The four independent directors of SulphCo(R), Inc. have responded to the lawsuit commenced by SulphCo's deposed Chairman and CEO, Dr. Rudolf W. Gunnerman, by asserting a counterclaim yesterday seeking a declaration that their action amending the By-laws was proper and detailing the violations by Dr. Gunnerman of the Company's policies and relevant federal securities laws that led the directors to act in the best interests of all shareholders by making the amendment.

      While Dr. Gunnerman mischaracterizes the recent directors' action as an attempt to "entrench themselves", the fact, as set forth in the directors' answer and counterclaim, is that these independent directors were compelled to act in order to protect the Company.

      Chairman of the Board, Robert van Maasdijk stated "It is unfortunate that these matters have been dragged into court, but we, as directors of SulphCo, (Nachrichten) will vigorously pursue all avenues to fulfill our duty to the Company and all of the shareholders. As the facts unfold, we believe that the directors will be vindicated. We feel strongly that under Dr. Ryan's new leadership we are now moving in the right direction."
      :cool:
      Avatar
      schrieb am 24.01.07 20:54:51
      Beitrag Nr. 7 ()
      Antwort auf Beitrag Nr.: 27.159.329 von DonauPirat am 24.01.07 20:02:33Michael Heffner, Former BP Executive, Rejoins SulphCo(R) Board
      Wednesday January 24, 2:06 pm ET


      SPARKS, Nev., Jan. 24 /PRNewswire-FirstCall/ -- SulphCo®, Inc. (Amex: SUF - News) announced today that Michael T. Heffner, a former executive with British Petroleum, has rejoined SulphCo's board.
      ADVERTISEMENT


      Heffner retired from BP in 2001 after 20 years with the company. From 1996 to 2001, he was President of BP Algeria, responsible for overseeing a $5 billion division comprising a petroleum producing property and two natural gas developments in the Middle East. Previously, he served as joint venture manager in Colombia, managing partner relationships with the Colombian State Oil Company and private partners Total and Triton for $2 billion in Colombian oil and gas development. During his career with the company, he also served as BP's health, safety and environmental manager for the Western Hemisphere.

      Prior to BP, Heffner spent ten years with Bechtel Corporation, where he served in a variety of cost, planning and construction roles in the company's petrochemical division in the U.S. and Canada.

      "I am pleased to rejoin the SulphCo® board. I look forward to working with the new management and helping the Company achieve its goals," Heffner said. "I continue to believe the Sonocracking(TM) technology is one of the most exciting breakthroughs I have observed in the petroleum industry."

      Dr. Larry Ryan, CEO of SulphCo® said, "We are pleased to have Michael back on the board. He is a true asset to our Company with his extensive experience in the petroleum industry and his existing knowledge of our Company and technology."

      Heffner earned his BS degree in chemical engineering from the Georgia Institute of Technology and a master's degree in business from Rice University.

      :rolleyes:
      Avatar
      schrieb am 25.01.07 10:11:13
      Beitrag Nr. 8 ()
      24.01.2007 22:43
      Dr. Gunnerman Issues Statement in Response to Counterclaim by Members of SulphCo's Board of Directors

      RENO, Nevada, Jan. 24 /PRNewswire/ -- Dr. Rudolph W. Gunnerman, the former CEO and a director of SulphCo, (Nachrichten) Inc. ("SulphCo"), as well as the Company's largest shareholder, today responded to the counterclaim filed by certain members of the Board of Directors of SulphCo in the Second Judicial District Court of the State of Nevada. Dr. Gunnerman previously filed suit against these directors to prevent them from stripping shareholders of their right to decide what bylaws should govern the Company by granting the Board of Directors the exclusive authority to amend, alter, add, rescind or repeal the Company's bylaws.

      "The accusations in the counterclaim filed today by certain members of SulphCo's Board of Directors are without merit. I intend to vigorously defend myself against these baseless allegations and I will continue to seek relief from the court in my effort to protect the rights of all shareholders," said Dr. Gunnerman. "While the counterclaim makes a number of vicious, personal attacks, it does not explain why certain members of SulphCo's Board are trying to deprive shareholders of their rights. I strongly believe that the directors' self-serving efforts to entrench themselves and advance their own interests directly contradict their obligation to act in the best interests of all SulphCo shareholders."
      :cool:
      Avatar
      schrieb am 25.01.07 10:17:43
      Beitrag Nr. 9 ()
      Antwort auf Beitrag Nr.: 27.160.406 von LongTT am 24.01.07 20:54:51Hello LongTT,
      willkommen an Bord;)
      Avatar
      schrieb am 26.01.07 13:33:54
      Beitrag Nr. 10 ()
      25.01.2007 19:58
      SulphCo(R) Announces Conference Call Details

      SPARKS, Nev., Jan. 25 /PRNewswire-FirstCall/ -- SulphCo(R), Inc. announces the details for the investor conference call on Monday, January 29th at 4:30 P.M. (EST) hosted by new Chairman of the Board, Robert van Massdijk and CEO, Dr. Larry Ryan.

      The call can be accessed in the U.S. by dialing 877-407-0778 and outside of the U.S. by dialing 201-689-8565. A teleconference replay of the call will be available through February 5, 2007, beginning approximately 1 hour after the conference call ends, by dialing 877-660-6853 in the U.S., or 201-612-7415 from outside of the U.S. To access the replay, the account number is 286 and the conference ID number is 229408.

      Listen to the live Web cast at http://www.vcall.com/IC/CEPage.asp?ID=113371. The webcast replay is available until February 5, 2007.
      :cool:
      Avatar
      schrieb am 06.02.07 12:49:25
      Beitrag Nr. 11 ()
      News Headlines :)

      Dr. Gunnerman, SulphCo's Founder, Resigns From Board of Directors
      05 Feb 07 18:16

      RENO, Nev., Feb. 5 /PRNewswire-FirstCall/ -- Dr. Rudolph W. Gunnerman, the founder, former chairman and CEO, and largest shareholder of SulphCo, Inc. ( Amex: SUF) ("SulphCo"), today announced that he has resigned from SulphCo' Board of Directors, effective immediately.


      "As SulphCo's largest shareholder, I remain committed to the success of the Company," said Dr. Gunnerman. "I have confidence in the Company's technology and bright future and I hope the current Board will successfully execute on the business plan to create value for all SulphCo shareholders."


      Contacts:
      Media:
      Andrew Siegel / Michael Cuneo
      (212) 355-4449
      Joele Frank, Wilkinson Brimmer Katcher

      Investors and Analysts:
      Charles Koons
      (212) 929-5500
      MacKenzie Partners, Inc.


      SOURCE Dr. Gunnerman
      Avatar
      schrieb am 07.02.07 23:28:24
      Beitrag Nr. 12 ()
      Antwort auf Beitrag Nr.: 27.460.217 von Naschi am 06.02.07 12:49:25ad donaupirat!

      ah, jetzt hab ich donaupirat zufaellig wieder gefunden. scheinst dich wieder mal fuer einen selben wert zu interessieren, den ich derzeit ein wenig analysiere.
      bist du eigentlich noch in s&t investiert. hoffe doch!!
      gruss, bluemax999

      ps: die wiener boerse scheint nicht zu stoppen, mal sehen bis wann?
      pss: versuch schon seit 2 monaten an frauenthal-aktien zu kommen, mein limit wird aber immer um haaresbreit nicht erfuellt.


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      SULPHCO - Facts only